Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burdenJulie Staals, Joanna M. Wardlaw, Stephen Makin et al.|Neurology|2014Cited by 1k
Neuroimaging standards for research into small vessel disease—advances since 2013Marco Duering, Hugh S. Markus, Frank‐Erik de Leeuw et al.|The Lancet Neurology|2023Cited by 962
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trialFloris H.B.M. Schreuder, Catharina J.M. Klijn, Koen M. van Nieuwenhuizen et al.|The Lancet Neurology|2021Cited by 101
Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic StrokeMohammed Almekhlafi, Tobien H.C.M.L. Schreuder, Mayank Goyal et al.|JAMA Neurology|2021Cited by 63